Impact BioMedical Financials - Benzinga

Impact BioMedical Inc

IBOAMEX

Trade with Public

Trade with Public

$0.4700

-0.0074-1.55%

In chiusura: Aug 18, 5:00 PM EST

Panoramica Notizie Previsioni utili EventiDati finanziariSentiment Azionariato Confronta Rapporto azionario

Impact BioMedical Financials

Impact BioMedical (IBO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Impact BioMedical Q1 EPS $(0.02) Up From $(0.11) YoY, Sales $7.000K

Impact BioMedical (AMEX:IBO) reported quarterly losses of $(0.02) per share. This is a 81.82 percent increase over losses of $(0.11) per share from the same period last year. The company reported $7.000 thousand in

Benzinga Newsdesk

PRO
Impact BioMedical Q2 EPS $(1.18), Sales $7.00K

Impact BioMedical (AMEX:IBO) reported quarterly losses of $(1.18) per share. The company reported $7.00 thousand in sales this quarter.

Benzinga Newsdesk

Crude Oil Falls 1%; US Services PMI Declines In June

Avi Kapoor

S&P 500 Gains 1%; April Jobs Top Expectations

Avi Kapoor

Dow Tumbles Over 400 Points; Nike Shares Dip After Q3 Results

Avi Kapoor

© 2026 Benzinga | All Rights Reserved